In addition, effectively reducing the expression of miR‐29c‐3p can significantly inhibit the proliferation, invasion and migration of TNBC cells, reduce the size of tumour growth and inhibit the expression of Ki‐67 in vivo (Figures S2 and S3). The gene discussed is MKI67; the disease is neoplasm.